Skip to main content

. 1996 Nov 9;313(7066):1184–1185. doi: 10.1136/bmj.313.7066.1184

Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.

M C Walker ¹, L M Li ¹, J W Sander ¹

PMCID: PMC2352496 PMID: 8916751

1184

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Klenerman P., Sander J. W., Shorvon S. D. Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):149–152. doi: 10.1136/jnnp.56.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
Nashef L., Fish D. R., Sander J. W., Shorvon S. D. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):462–464. doi: 10.1136/jnnp.58.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sander J. W., Trevisol-Bittencourt P. C., Hart Y. M., Patsalos P. N., Shorvon S. D. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Epilepsy Res. 1990 Dec;7(3):226–229. doi: 10.1016/0920-1211(90)90019-r. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES